文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

元研究评估健康研究中新研究规划时系统评价的冗余和使用:范围综述。

Meta-research evaluating redundancy and use of systematic reviews when planning new studies in health research: a scoping review.

机构信息

Section Evidence-Based Practice, Department for Health and Function, Western Norway University of Applied Sciences, Inndalsveien 28, P.O.Box 7030, N-5020, Bergen, Norway.

Division of General Internal Medicine, Department of Medicine, Johns Hopkins University, Baltimore, MD, USA.

出版信息

Syst Rev. 2022 Nov 15;11(1):241. doi: 10.1186/s13643-022-02096-y.


DOI:10.1186/s13643-022-02096-y
PMID:36380367
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9667610/
Abstract

BACKGROUND: Several studies have documented the production of wasteful research, defined as research of no scientific importance and/or not meeting societal needs. We argue that this redundancy in research may to a large degree be due to the lack of a systematic evaluation of the best available evidence and/or of studies assessing societal needs. OBJECTIVES: The aim of this scoping review is to (A) identify meta-research studies evaluating if redundancy is present within biomedical research, and if so, assessing the prevalence of such redundancy, and (B) to identify meta-research studies evaluating if researchers had been trying to minimise or avoid redundancy. ELIGIBILITY CRITERIA: Meta-research studies (empirical studies) were eligible if they evaluated whether redundancy was present and to what degree; whether health researchers referred to all earlier similar studies when justifying and designing a new study and/or when placing new results in the context of earlier similar trials; and whether health researchers systematically and transparently considered end users' perspectives when justifying and designing a new study. SOURCES OF EVIDENCE: The initial overall search was conducted in MEDLINE, Embase via Ovid, CINAHL, Web of Science, Social Sciences Citation Index, Arts & Humanities Citation Index, and the Cochrane Methodology Register from inception to June 2015. A 2nd search included MEDLINE and Embase via Ovid and covered January 2015 to 26 May 2021. No publication date or language restrictions were applied. CHARTING METHODS: Charting methods included description of the included studies, bibliometric mapping, and presentation of possible research gaps in the identified meta-research. RESULTS: We identified 69 meta-research studies. Thirty-four (49%) of these evaluated the prevalence of redundancy and 42 (61%) studies evaluated the prevalence of a systematic and transparent use of earlier similar studies when justifying and designing new studies, and/or when placing new results in context, with seven (10%) studies addressing both aspects. Only one (1%) study assessed if the perspectives of end users had been used to inform the justification and design of a new study. Among the included meta-research studies evaluating whether redundancy was present, only two of nine health domains (medical areas) and only two of 10 research topics (different methodological types) were represented. Similarly, among the included meta-research studies evaluating whether researchers had been trying to minimise or avoid redundancy, only one of nine health domains and only one of 10 research topics were represented. CONCLUSIONS THAT RELATE TO THE REVIEW QUESTIONS AND OBJECTIVES: Even with 69 included meta-research studies, there was a lack of information for most health domains and research topics. However, as most included studies were evaluating across different domains, there is a clear indication of a high prevalence of redundancy and a low prevalence of trying to minimise or avoid redundancy. In addition, only one meta-research study evaluated whether the perspectives of end users were used to inform the justification and design of a new study. SYSTEMATIC REVIEW REGISTRATION: Protocol registered at Open Science Framework: https://osf.io/3rdua/ (15 June 2021).

摘要

背景:多项研究记录了浪费性研究的产生,这些研究被定义为没有科学重要性且/或不符合社会需求的研究。我们认为,研究中的这种冗余在很大程度上是由于缺乏对最佳现有证据的系统评估,以及/或者缺乏评估社会需求的研究。

目的:本次范围综述的目的是:(A) 确定评价生物医学研究中是否存在冗余的元研究,若存在,则评估这种冗余的普遍程度;以及 (B) 确定评价研究人员是否试图最小化或避免冗余的元研究。

入选标准:如果元研究评估了是否存在冗余及其程度、健康研究人员在为新研究提供依据和设计时是否参考了所有先前类似的研究,以及/或者在将新结果置于早期类似试验的背景下时是否参考了所有先前类似的研究;以及健康研究人员在为新研究提供依据和设计时是否系统和透明地考虑了最终用户的观点,则元研究(实证研究)符合入选标准。

证据来源:最初的全面搜索在 MEDLINE、Embase 通过 Ovid、CINAHL、Web of Science、Social Sciences Citation Index、Arts & Humanities Citation Index 和 Cochrane 方法学登记处进行,从创建到 2015 年 6 月。第二次搜索包括 MEDLINE 和 Embase 通过 Ovid,并涵盖了 2015 年 1 月至 2021 年 5 月 26 日。未对出版物日期或语言进行限制。

图表方法:图表方法包括描述纳入的研究、文献计量制图以及展示已识别的元研究中可能存在的研究空白。

结果:我们确定了 69 项元研究。其中 34 项(49%)评估了冗余的普遍性,42 项(61%)研究评估了在为新研究提供依据和设计时,以及/或者在将新结果置于背景下时,系统透明地使用先前类似研究的普遍性,其中 7 项(10%)研究同时评估了这两个方面。只有一项(1%)研究评估了最终用户的观点是否被用于为新研究提供依据和设计。在所纳入的评估是否存在冗余的元研究中,仅在 9 个健康领域(医学领域)中的 2 个和 10 个研究主题(不同的方法类型)中得到了体现。同样,在所纳入的评估研究人员是否试图最小化或避免冗余的元研究中,9 个健康领域和 10 个研究主题中仅各有 1 个得到了体现。

与审查问题和目标相关的结论:即使纳入了 69 项元研究,大多数健康领域和研究主题仍缺乏信息。然而,由于大多数纳入的研究都是在不同的领域进行评估,因此有明确的迹象表明存在高度的冗余普遍性和低度的试图最小化或避免冗余普遍性。此外,只有一项元研究评估了最终用户的观点是否被用于为新研究提供依据和设计。

系统评价注册:方案在 Open Science Framework 上注册:https://osf.io/3rdua/(2021 年 6 月 15 日)。

相似文献

[1]
Meta-research evaluating redundancy and use of systematic reviews when planning new studies in health research: a scoping review.

Syst Rev. 2022-11-15

[2]
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.

Cochrane Database Syst Rev. 2022-2-1

[3]
Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.

Med J Aust. 2020-12

[4]
The future of Cochrane Neonatal.

Early Hum Dev. 2020-11

[5]
Bias due to selective inclusion and reporting of outcomes and analyses in systematic reviews of randomised trials of healthcare interventions.

Cochrane Database Syst Rev. 2014-10-1

[6]
Eliciting adverse effects data from participants in clinical trials.

Cochrane Database Syst Rev. 2018-1-16

[7]
A systematic review of meta-research studies finds substantial methodological heterogeneity in citation analyses to monitor evidence-based research.

J Clin Epidemiol. 2022-10

[8]
Search strategies (filters) to identify systematic reviews in MEDLINE and Embase.

Cochrane Database Syst Rev. 2023-9-8

[9]
Ethics of Procuring and Using Organs or Tissue from Infants and Newborns for Transplantation, Research, or Commercial Purposes: Protocol for a Bioethics Scoping Review.

Wellcome Open Res. 2024-12-5

[10]
Justification of research using systematic reviews continues to be inconsistent in clinical health science-A systematic review and meta-analysis of meta-research studies.

PLoS One. 2022

引用本文的文献

[1]
Why is it important to implement meta-research in universities and institutes with medical research activities?

Front Res Metr Anal. 2025-3-19

[2]
Use of Digital Health Technologies for Dementia Care: Bibliometric Analysis and Report.

JMIR Ment Health. 2025-2-10

[3]
Evidence-based research.

Syst Rev. 2024-12-23

[4]
Several methods for assessing research waste in reviews with a systematic search: a scoping review.

PeerJ. 2024

[5]
How can meta-research be used to evaluate and improve the quality of research in the field of traditional, complementary, and integrative medicine?

Integr Med Res. 2024-9

[6]
Identifying meta-research with researchers as study subjects: Protocol for a scoping review.

PLoS One. 2024

[7]
Use of Evidence-Based Research Approach in RCTs of Acupuncture-Related Therapies for Primary Dysmenorrhea: A Meta-Research.

Chin J Integr Med. 2024-6

[8]
Assessment of redundancy, methodological and reporting quality, and potential discrepancies of results of systematic reviews of early mobilisation of critically ill adults: a meta-research protocol.

BMJ Open. 2023-7-20

[9]
Evidence-based health policy in Germany: lack of communication and coordination between academia and health authorities?

Syst Rev. 2023-3-13

本文引用的文献

[1]
Towards a Research Agenda for Promoting Responsible Research Practices.

J Empir Res Hum Res Ethics. 2021-10

[2]
Effect of redundant clinical trials from mainland China evaluating statins in patients with coronary artery disease: cross sectional study.

BMJ. 2021-2-2

[3]
Evidence-Based Research Series-Paper 1: What Evidence-Based Research is and why is it important?

J Clin Epidemiol. 2021-1

[4]
Scoping review of priority setting of research topics for musculoskeletal conditions.

BMJ Open. 2018-12-16

[5]
PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation.

Ann Intern Med. 2018-9-4

[6]
The prevalence of patient engagement in published trials: a systematic review.

Res Involv Engagem. 2018-5-22

[7]
Ranking major and minor research misbehaviors: results from a survey among participants of four World Conferences on Research Integrity.

Res Integr Peer Rev. 2016-11-21

[8]
Going from evidence to recommendations: Can GRADE get us there?

J Eval Clin Pract. 2018-10

[9]
Citation of prior research has increased in introduction and discussion sections with time: A survey of clinical trials in physiotherapy.

Clin Trials. 2017-8

[10]
Why do authors derive new cardiovascular clinical prediction rules in the presence of existing rules? A mixed methods study.

PLoS One. 2017-6-7

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索